|
US5268454A
(en)
*
|
1991-02-08 |
1993-12-07 |
La Jolla Pharmaceutical Company |
Composition for inducing humoral anergy to an immunogen comprising a t cell epitope-deficient analog of the immunogen conjugated to a nonimmunogenic carrier
|
|
KR100361933B1
(ko)
*
|
1993-09-08 |
2003-02-14 |
라 졸라 파마슈티칼 컴파니 |
화학적으로정의된비중합성결합가플랫폼분자및그것의콘주게이트
|
|
US6410775B1
(en)
*
|
1995-06-07 |
2002-06-25 |
La Jolla Pharmaceutical Company |
APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
|
|
US5874409A
(en)
|
1995-06-07 |
1999-02-23 |
La Jolla Pharmaceutical Company |
APL immunoreactive peptides, conjugates thereof and methods of treatment for APL antibody-mediated pathologies
|
|
US5817752A
(en)
*
|
1996-06-06 |
1998-10-06 |
La Jolla Pharmaceutical Company |
Cyclic polypeptides comprising a thioether linkage and methods for their preparation
|
|
JP2000512981A
(ja)
*
|
1996-06-06 |
2000-10-03 |
ラ ホヤ ファーマシューティカル カンパニー |
ａＰＬ免疫応答性ペプチド、その結合体およびａＰＬ抗体媒介病理のための処置方法
|
|
US6812327B1
(en)
*
|
1996-10-25 |
2004-11-02 |
Human Genome Sciences, Inc. |
Neutrokine-alpha polypeptides
|
|
US8212004B2
(en)
*
|
1999-03-02 |
2012-07-03 |
Human Genome Sciences, Inc. |
Neutrokine-alpha fusion proteins
|
|
US6858210B1
(en)
|
1998-06-09 |
2005-02-22 |
La Jolla Pharmaceutical Co. |
Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
|
|
US20050197283A1
(en)
*
|
1998-10-04 |
2005-09-08 |
Vascular Biogenics Ltd. |
Compositions containing beta 2-glycoprotein I for the prevention and/or treatment of vascular disease
|
|
IL126447A
(en)
*
|
1998-10-04 |
2004-09-27 |
Vascular Biogenics Ltd |
An immune preparation that confers tolerance in oral administration and its use in the prevention and / or treatment of atherosclerosis
|
|
US6399578B1
(en)
*
|
1998-12-09 |
2002-06-04 |
La Jolla Pharmaceutical Company |
Conjugates comprising galactose α1,3 galactosyl epitopes and methods of using same
|
|
US20010010818A1
(en)
*
|
1998-12-09 |
2001-08-02 |
Engle Steven B. |
Methods and formulations for reducing circulating antibodies
|
|
US6458953B1
(en)
*
|
1998-12-09 |
2002-10-01 |
La Jolla Pharmaceutical Company |
Valency platform molecules comprising carbamate linkages
|
|
CA2376057A1
(en)
*
|
1999-06-08 |
2000-12-14 |
La Jolla Pharmaceutical Company |
Valency platform molecules comprising aminooxy groups
|
|
AUPQ272699A0
(en)
*
|
1999-09-09 |
1999-09-30 |
Unisearch Limited |
Use of beta2GPI in diagnostic tests for autoimmune diseases
|
|
CN101422614A
(zh)
*
|
1999-11-28 |
2009-05-06 |
拉卓拉药物公司 |
基于抗体亲和力来治疗狼疮的方法及使用这种方法的筛选方法和组合物
|
|
DK1272647T3
(en)
|
2000-04-11 |
2014-12-15 |
Genentech Inc |
Multivalent antibodies and uses thereof
|
|
US6951939B2
(en)
|
2000-06-08 |
2005-10-04 |
La Jolla Pharmaceutical Company |
Multivalent platform molecules comprising high molecular weight polyethylene oxide
|
|
EP2275449B1
(en)
*
|
2000-06-16 |
2016-09-28 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to BLyS
|
|
US7879328B2
(en)
*
|
2000-06-16 |
2011-02-01 |
Human Genome Sciences, Inc. |
Antibodies that immunospecifically bind to B lymphocyte stimulator
|
|
ATE451390T1
(de)
*
|
2000-08-18 |
2009-12-15 |
Dyax Corp |
Polypeptide zur bindung an das b-lymphozyten- stimulatorische protein (blys)
|
|
US20030091565A1
(en)
*
|
2000-08-18 |
2003-05-15 |
Beltzer James P. |
Binding polypeptides and methods based thereon
|
|
WO2002097051A2
(en)
*
|
2001-05-30 |
2002-12-05 |
Gene Therapy Systems, Inc. |
Protein arrays and methods and systems for producing the same
|
|
AU2002345847B2
(en)
|
2001-06-21 |
2008-05-29 |
Dynavax Technologies Corporation |
Chimeric immunomodulatory compounds and methods of using the same
|
|
US20030114405A1
(en)
*
|
2001-08-13 |
2003-06-19 |
Linnik Matthew D. |
Methods of treating systemic lupus erythematosus in individuals having significantly impaired renal function
|
|
US7105135B2
(en)
*
|
2001-10-16 |
2006-09-12 |
Lockheed Martin Corporation |
System and method for large scale detection of hazardous materials in the mail or in other objects
|
|
JP2005512043A
(ja)
*
|
2001-12-03 |
2005-04-28 |
アブジェニックス・インコーポレーテッド |
治療剤産物の発見
|
|
US7771951B2
(en)
|
2001-12-03 |
2010-08-10 |
Amgen Fremont Inc. |
Antibody categorization based on binding characteristics
|
|
US7754433B2
(en)
*
|
2001-12-03 |
2010-07-13 |
Amgen Fremont Inc. |
Identification of high affinity molecules by limited dilution screening
|
|
US7354897B2
(en)
*
|
2002-06-07 |
2008-04-08 |
Brigham & Women's Hospital, Inc. |
Method and composition for inhibiting or slowing blood coagulation
|
|
US7884083B2
(en)
|
2002-08-12 |
2011-02-08 |
Dynavax Technologies Corporation |
Immunomodulatory compositions, methods of making, and methods of use thereof
|
|
AU2003303524A1
(en)
*
|
2002-12-27 |
2004-07-29 |
La Jolla Pharmaceutical Company |
Methods of improving health-related quality of life in individuals with systemic lupus erythematosus
|
|
WO2004089422A2
(en)
*
|
2003-03-30 |
2004-10-21 |
La Jolla Pharmaceutical Co. |
Methods of treating and monitoring systemic lupus erythematosus in individuals
|
|
WO2005005954A2
(en)
*
|
2003-06-30 |
2005-01-20 |
The Brigham & Women's Hospital, Inc. |
Method, composition and kit for detecting phosphatidylserine (ps) on cell membranes
|
|
US9062392B2
(en)
*
|
2003-12-30 |
2015-06-23 |
Intel Corporation |
Methods for isolating a peptide methods for identifying a peptide
|
|
SI1794174T1
(sl)
|
2004-09-01 |
2012-09-28 |
Dynavax Tech Corp |
Postopki in sestavki za inhibiranje prirojenih imunskih odzivov in avtoimunosti
|
|
JP5335239B2
(ja)
*
|
2004-09-30 |
2013-11-06 |
マイオスティン・セラピューティクス・プロプライエタリー・リミテッド |
ミオスタチンアイソフォーム
|
|
DK1853631T3
(en)
*
|
2005-01-24 |
2016-03-29 |
Univ Texas |
Fc-FUSION CONSTRUCTIONS BINDING TO PHOSPHATIDYLSERINE AND THERAPEUTIC APPLICATION THEREOF
|
|
EP1874334A4
(en)
*
|
2005-04-15 |
2011-03-30 |
Vascular Biogenics Ltd |
COMPOSITIONS WITH BETA 2-GLYCOPROTEIN I-PEPTIDES FOR THE PREVENTION AND / OR TREATMENT OF VASCULAR DISEASES
|
|
EA015860B1
(ru)
*
|
2005-10-13 |
2011-12-30 |
Хьюман Дженом Сайенсиз, Инк. |
Способы лечения аутоиммунных заболеваний при использовании антагониста нейтрокина-альфа
|
|
US9168286B2
(en)
*
|
2005-10-13 |
2015-10-27 |
Human Genome Sciences, Inc. |
Methods and compositions for use in treatment of patients with autoantibody positive disease
|
|
US8211649B2
(en)
*
|
2006-03-31 |
2012-07-03 |
Human Genome Sciences, Inc. |
Methods of diagnosing and prognosing hodgkin's lymphoma
|
|
US8309068B2
(en)
*
|
2006-08-03 |
2012-11-13 |
Myostin Therapeutics Pty Ltd. |
Isolated polypeptides and methods of improving muscle strength
|
|
US7847019B2
(en)
*
|
2007-10-15 |
2010-12-07 |
California Institute Of Technology |
Functionalized polymers using protected thiols
|
|
CA2703931C
(en)
|
2007-10-26 |
2016-08-16 |
Dynavax Technologies Corporation |
Methods and compositions for inhibition of immune responses and autoimmunity
|
|
WO2010093993A2
(en)
*
|
2009-02-12 |
2010-08-19 |
Human Genome Sciences, Inc. |
Use of b lymphocyte stimulator protein antagonists to promote transplantation tolerance
|
|
BR112012032240A2
(pt)
|
2010-06-16 |
2019-09-24 |
Dynavax Technologies Corporation |
método de tratamento utilizando inibidores tlr7 e/ou tlr9
|
|
US9228184B2
(en)
|
2012-09-29 |
2016-01-05 |
Dynavax Technologies Corporation |
Human toll-like receptor inhibitors and methods of use thereof
|
|
CN105353137A
(zh)
*
|
2015-12-10 |
2016-02-24 |
中国农业科学院饲料研究所 |
一种快速检测色素苏丹红的方法
|
|
CN112789295B
(zh)
*
|
2018-10-10 |
2023-08-15 |
国立大学法人鹿儿岛大学 |
包含IgG结合肽的固相担载体及IgG的分离方法
|
|
WO2022197295A1
(en)
*
|
2021-03-17 |
2022-09-22 |
Milliken & Company |
Polymeric colorants with reduced staining
|